BAY1067197
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY1067197, covering 2019-09-19 to 2019-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety of BAY1067197 in Stable Heart Failure Patients on Standard Therapy Including ß-blocker [Phase 2]